Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| ELI LILLY AND COMPANY | LLY | Nyse +13 Other | 3,013,916 |
770
USD
 | Stock | |
| ELI LILLY AND COMPANY | LLY | Swiss Exchange | 7 |
685
CHF
| ||
| ELI LILLY AND COMPANY | LLY | Deutsche Boerse AG | 451 |
709.2
EUR
| ||
| ELI LILLY AND COMPANY | LLY | Frankfurt | 3,522 |
708.6
EUR
| ||
| ELI LILLY AND COMPANY | LEL | London S.E. | 539 |
225.3
CHF
| ||
| ELI LILLY AND COMPANY | LLY * | Mexican S.E. | 298 |
12,917
MXN
| ||
| ELI LILLY AND COMPANY | LLY | Euronext Paris | 47 |
98
EUR
| ||
| ELI LILLY AND COMPANY | LLY | Börse Stuttgart | 330 |
707.5
EUR
| ||
| ELI LILLY AND COMPANY | LLYC | Wiener Boerse | 7 |
713.9
EUR
| ||
| ELI LILLY AND COMPANY | LLY | BOERSE MUENCHEN | 859 |
707.7
EUR
| ||
| ELI LILLY AND COMPANY | 4LLY | Borsa Italiana | - |
716.5
EUR
| ||
| ELI LILLY AND COMPANY | LLY | Berne S.E. | 20 |
684.5
CHF
| ||
| ELI LILLY AND COMPANY | LLY | Bulgaria S.E. | 0 |
708.6
EUR
| ||
| ELI LILLY AND COMPANY | Lima | - |
769.8
USD
| |||
| ELI LILLY AND COMPANY | LLY | NEO Exchange +2 Other | 39,517 |
29
CAD
| Stock | |
| ELI LILLY AND COMPANY | LLY0 | Deutsche Boerse AG | - |
18.6
EUR
| ||
| ELI LILLY AND COMPANY | LLY0 | BOERSE MUENCHEN | - |
19.6
EUR
| ||
| ELI LILLY AND COMPANY | LLY | Buenos Aires S.E. +1 Other | 2,324 |
15,190
ARS
| Stock | |
| ELI LILLY AND COMPANY | LLYD | Buenos Aires S.E. | 69 |
15.2
USD
| ||
| ELI LILLY AND COMPANY | LILY34 | Sao Paulo | 11,811 |
131
BRL
| Stock | |
| STEVEN MADDEN, LTD. | SHOO | Nasdaq +4 Other | 686,150 |
41.66
USD
| Stock | |
| STEVEN MADDEN, LTD. | SJM | Deutsche Boerse AG | - |
38
EUR
| ||
| STEVEN MADDEN, LTD. | SJM | BOERSE MUENCHEN | - |
38.4
EUR
| ||
| STEVEN MADDEN, LTD. | SJM | Berne S.E. | - | - CHF
| ||
| STEVEN MADDEN, LTD. | SJM | Börse Stuttgart | - |
38.2
EUR
| ||
| ELI LILLY & CO - DIVIDEND (ZX8) - ELA/C1 | Euronext Amsterdam | - |
3.92
USD
| Future | ||
| ELI LILLY & CO - DIVIDEND (ZX8) - ELA/C4 | Euronext Amsterdam | - |
3.92
USD
| Future | ||
| ELI LILLY & CO - DIVIDEND (ZX8) - ELA/20250117 | Euronext Amsterdam | - |
3.92
USD
| Future | ||
| ELI LILLY & CO - DIVIDEND (ZX8) - ELA/20270115 | Euronext Amsterdam | - |
3.92
USD
| Future | ||
| ELI LILLY & CO - DIVIDEND (ZX8) - ELA/20260116 | Euronext Amsterdam | - |
3.92
USD
| Future |
News (760)
Companies (17)
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Biopharm SPA is one of the leading pharmaceutical groups in Algeria. The group manufactures generic pharmaceuticals under its own brands, as well as licensed drugs for laboratories such as Sanofi, Eli Lilly and Pierre Fabre. At the end of 2022, Biopharm ...
Oxford Industries, Inc. operates in the apparel industry, which owns and markets Tommy Bahama, Lilly Pulitzer, Johnny Was, Southern Tide, The Beaufort Bonnet Company and Duck Head lifestyle brands. The Company distributes its products through its direct-t ...
PSB Holdings, Inc. is a holding company for Peoples State Bank (Peoples). Peoples is a community bank, which serves north central and southeastern Wisconsin with 10 full-service banking locations in Marathon, Oneida, Vilas, Milwaukee and Waukesha counties ...
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosi ...
Hammer Metals Limited is an Australia-based company, which is involved in mineral exploration in Western Australia and Queensland. The Companyâs projects include Bronzewing South Au/Li/Ni Project and Mount Isa Projects. The Bronzewing South Project is l ...
Arab Palestinian Investment Company, Ltd. (APIC) is a Jordan-based company that is engaged in the investment activities in the Palestinian market businesses. APIC, along with its subsidiaries and associated companies, is involved in the manufacturing, dis ...
Insiders
Steven L.
Lilly is currently a Trustee at The Leukemia & Lymphoma Society, Inc. He previously worked as a Senior Vice President at National Rural Utilities Cooperative Finance Corp.
from 2013 to 2016.
He also worked as a Principal at CFC Advantage LLC and as a Chief Financial Officer at National Cooperative Services Corp.
Mr. Lilly received his undergraduate degree and MBA from Drexel University.
Mr. Steven R.
Lilly, CFA MBA, is a Managing Director at Silvercrest Asset Management Group LLC.
He joined Silvercrest in 2019 as a result of Silvercrest’s acquisition of Cortina Asset Management, where he was a Portfolio Manager.
He has more than 25 years of experience in the investment industry.
He provides in-depth research on health care, energy, and consumer sectors.
Mr. Lilly has been an institutional investor focused on small and mid-cap growth equities since 1996, spending the first decade of his career with Stein, Roe & Farnham, now known as Columbia Threadneedle.
After five years as an Equity Research Analyst, he began managing small and mid-cap mutual fund and institutional assets in 2001.
After leaving Columbia Management Group in 2005, he served as Portfolio Manager at Peak6 Investments, a leading options trading firm.
Mr. Lilly received a B.S.
from Indiana University and an M.B.A.
from the University of Chicago Booth School of Business.
He holds the Chartered Financial Analyst designation and is a Member of the CFA Institute.
Steven C. Lilly founded Barings BDC, Inc. and Triangle Capital Corp. (Private Equity). Mr. Lilly occupies the position of Chief Financial Officer of FS KKR Capital Corp. II and Chief Financial Officer at FS KKR Capital Corp. He is also on the board of 7 other companies. In the past Mr. Lilly was Senior Managing Director, CFO & Secretary at Triangle Capital Corp. (Private Equity), Chief Financial Officer & Treasurer at SpectraSite, Inc., Chief Financial Officer, Secretary & Director at Barings BDC, Inc., Chief Financial Officer of FS Investment Corp. III, Chief Financial Officer for Triangle Capital Partners LLC, Chief Financial Officer of FS Investment Corp. IV and Vice President-Media & Communications Group at First Union Capital Markets Corp. He received an undergraduate degree from Davidson College.
No results for this search
- Stock Market
- Advanced search
- Steven Lilly
